The core activity of SAWO ONCOLOGY GmbH is to provide consulting and services in the field of clinical development of medicines and treatments for cancer, hematology, palliative medicine, and internal medicine. This includes, among other things: development of clinical and marketing strategies, conduct of clinical trials (Phase I-III), creation of clinical documentation and approval applications (eCTD, NDA), due diligence reviews of business opportunities, medical writing services and preparation of market launches, expert consulting for medical treatments and 'second opinion' services, and university teaching and lectures. The company thus offers a broad range of services to pharmaceutical companies, hospitals, and other healthcare customers to support the development and deployment of cancer medicines and treatments.